Incyte

(NASDAQ) INCY

Current Price$113.86

Market Cap$21.48B

Since IPO (1993)+5,967%

5 Year+31%

1 Year+61%

1 Month+17%

Incyte Financials at a Glance

Market Cap

$21.48B

Revenue (TTM)

$5.36B

Net Income (TTM)

$1.43B

EPS (TTM)

$7.07

P/E Ratio

15.21

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$113.86

Volume

100,451

Open

$109.75

Price

$113.86

Volume

100,451

Open

$109.75

Previous Close

$113.86

Daily Range

$109.75 - $115.48

52-Week Range

$66.83 - $115.56

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$113.86

Volume

100,451

Open

$109.75

Previous Close

$113.86

Daily Range

$109.75 - $115.48

52-Week Range

$66.83 - $115.56

Estimated Earnings Date

Aug 4, 2026

INCY News

Page 1

INCY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Incyte

Industry

Biotechnology

Sector

Health Care

Employees

2,844

CEO

William J. Meury

Website

www.incyte.com

Headquarters

Wilmington, DE 19803, US

INCY Financials

Key Financial Metrics (TTM)

Gross Margin

92.48%

Operating Margin

27.05%

Net Income Margin

26.71%

Return on Equity

29.31%

Return on Capital

25.64%

Return on Assets

19.51%

Earnings Yield

6.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.48B

Shares Outstanding

199.78M

Volume

100.45K

Avg. Volume

1.62M

Financials (TTM)

Gross Profit

$4.96B

Operating Income

$1.45B

EBITDA

$1.87B

Operating Cash Flow

$1.52B

Capital Expenditure

-$65.90M

Free Cash Flow

$1.45B

Cash & ST Invst.

$4.02B

Total Debt

$33.83M

Incyte Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.27B

+20.9%

Gross Profit

$1.17B

+19.2%

Gross Margin

91.79%

N/A

Market Cap

$21.48B

N/A

Market Cap/Employee

$8.21M

N/A

Employees

2,617

N/A

Net Income

$303.33M

+91.7%

EBITDA

$367.97M

+43.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$4.02B

+66.7%

Total Debt

$33.83M

-21.5%

Accounts Receivable

$1.05B

+27.7%

Inventory

$115.62M

+80.7%

Long Term Debt

$29.41M

-9.9%

Short Term Debt

$4.41M

-57.9%

Return on Assets

19.51%

N/A

Return on Invested Capital

24.79%

N/A

Free Cash Flow

$359.15M

+36.6%

Operating Cash Flow

$369.35M

+38.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UTHRUnited Therapeutics Corporation

UTHRUnited Therapeutics Corporation$542.66-0.13%

DGXQuest Diagnostics Incorporated

DGXQuest Diagnostics Incorporated$209.88+1.76%

RPRXRoyalty Pharma plc

RPRXRoyalty Pharma plc$56.23+2.82%

WATWaters Corporation

WATWaters Corporation$374.41-0.66%

WSTWest Pharmaceutical Services, Inc.

WSTWest Pharmaceutical Services, Inc.$350.85+1.24%

ZBHZimmer Biomet Holdings, Inc.

ZBHZimmer Biomet Holdings, Inc.$93.10+2.35%

THCTenet Healthcare Corporation

THCTenet Healthcare Corporation$189.00+2.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

NWLNewell Brands

NWLNewell Brands$5.82-0.01%

WENWendy's

WENWendy's$7.80+0.06%

Questions About INCY

What is the current price of Incyte?

Incyte is trading at $113.86 per share.

What is the 52-week range for Incyte?

Over the past 52 weeks, Incyte has traded between $66.83 and $115.56.

How much debt does Incyte have?

As of the most recent reporting period, Incyte reported total debt of $39.43M.

How much cash does Incyte have on hand?

Incyte reported $3.46B in cash and cash equivalents in its most recent financial results.

What is Incyte’s dividend yield?

Incyte does not currently have a dividend yield.

Incyte

Incyte Financials at a Glance

INCY News

Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000

Why Incyte Stock Was Tanking This Week

Incyte Surpasses Q3 Revenue Estimates

3 Stocks the World's Smartest Investors Are Buying Hand Over Fist Right Now

2 Under-the-Radar Biotech Stocks to Buy in 2022

Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start

Is the PD-(L)1 Party Over After Incyte's FDA Rejection?

2 Stocks Under $100 You Can Buy and Hold Forever

INCY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Incyte

INCY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Incyte Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INCY

What is the current price of Incyte?

What is the 52-week range for Incyte?

How much debt does Incyte have?

How much cash does Incyte have on hand?

What is Incyte’s dividend yield?

Premium Investing Services